A Review of the Current Cervical Cancer Screening Guidelines

References

1. ↵
   Dr. Pap's smear: the test and its times. American Medical News. September 3, 2007. http://www.amednews.com/article/20070903/health/309039956/4/. Accessed July 1, 2016.
2. ↵
   1. Saslow D,
   2. Solomon D,
   3. Lawson HW, et al., American Cancer Society, American Society for Colposcopy and Cervical Pathology, American Society for Clinical Pathology

   American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147-172. [Also published in Am J Clin Pathol. 2012;137(4):516-542.]

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Moyer VA, US Preventive Services Task Force

   Screening for cervical cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156(12):880-891.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Bernard VB,
   2. Watson M,
   3. Castle PE,
   4. Saraiya M

   Cervical carcinoma rates among young females in the United States. Obstet Gynecol. 2012;120(5):1117-1123.

   OpenUrlPubMedWeb of Science
5. ↵
   1. Massad LS,
   2. Einstein MH,
   3. Huh WK, et al., 2012 ASCCP Consensus Guidelines Conference

   2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17(5 Suppl 1):S1-S27.

   OpenUrlCrossRefPubMed
6. ↵
   1. Dillner J,
   2. Rebolj M,
   3. Birembaut P, et al., Joint European Cohort Study

   Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008;337:a1754.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Miller MG,
   2. Sung HY,
   3. Sawaya GF,
   4. Kearney KA,
   5. Kinney W,
   6. Hiatt RA

   Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol. 2003;101(1):29-37.

   OpenUrlCrossRefPubMed
8. ↵
   1. Wall CKB

   Pathologist's Corner – Dr. KB Wall on recent changes in guidelines for cervical cancer screening. SEPA Labs website. http://www.sepalabs.com/pathologists-corner/pathologists-corner-dr-kinzer-bezanson-on-recent-changes-in-guidelines-for-cervical-cancer-screening/. Published October 10, 2014. Accessed April 12, 2016.
9. ↵
   1. Dinkelspiel H,
   2. Fetterman B,
   3. Poitras N, et al.

   Screening history preceding a diagnosis of cervical cancer in women age 65 and older. Gynecol Oncol. 2012;126(2):203-206.

   OpenUrlPubMed
10. ↵
    1. Skinner EN,
    2. Gerhig PA,
    3. Van Le L

    High-grade squamous intraepithelial lesions: abbreviating posttreatment surveillance. Obstet Gynecol. 2004;103(3):488-492.

    OpenUrlPubMed
11. ↵
    1. Piscitelli JT,
    2. Bastian LA,
    3. Wilkes A,
    4. Simel DL

    Cytologic screening after hysterectomy for benign disease. Am J Obstet Gynecol. 1995;173(2):424-430.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Centers for Disease Control and Prevention (CDC)

    HIV Infection: Detection, Counseling, and Referral. CDC website. http://www.cdc.gov/std/treatment/2010/hiv.htm. Accessed June 30, 2016.
13. ↵
    1. Kaplan JE,
    2. Benson C,
    3. Holmes KK,
    4. Brooks JT,
    5. Pau A,
    6. Masur H, Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America

    Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1-207.

    OpenUrlPubMed